Arbutus Biopharma
ABUS
#6260
Rank
C$0.87 B
Marketcap
$4.59
Share price
-7.98%
Change (1 day)
13.00%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2024 (TTM): -C$95.94 Million

According to Arbutus Biopharma 's latest financial reports the company's current earnings are C$6.17 Million. , an increase over its 2023 earnings that were of -C$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -C$99.4 Million-4.02%
2023 -C$0.11 Billion12.05%
2022 -C$92.43 Million-14.74%
2021 -C$0.11 Billion19.61%
2020 -C$90.62 Million-61.69%
2019 -C$0.24 Billion171.23%
2018 -C$87.21 Million-43.58%
2017 -C$0.16 Billion-77.77%
2016 -C$0.7 Billion532.77%
2015 -C$0.11 Billion99.05%
2014 -C$55.22 Million175.82%
2013 -C$20.02 Million-143.7%
2012 C$45.8 M-399.11%
2011 -C$15.32 Million-39.03%
2010 -C$25.12 Million100.55%
2009 -C$12.53 Million-28.56%
2008 -C$17.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$50.15 M-150.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$3.08 Million-96.91% Bahamas